Tamsulosin Hydrochloride
Loading...Tamsulosin Hydrochloride Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Tamsulosin hydrochloride capsules, USP are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies (14)]. Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension.
History
There is currently no drug history available for this drug.
Other Information
Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.
Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white or almost white crystalline powder that melts with decomposition at approximately 230°C. It is slightly soluble in water, freely soluble in formic acid, slightly soluble in anhydrous ethanol, sparingly soluble in methanol, slightly soluble in glacial acetic acid, and practically insoluble in ether.
The molecular formula of tamsulosin hydrochloride is C20H28N2O5S • HCl. The molecular weight of tamsulosin hydrochloride is 444.98. Its structural formula is:
Each tamsulosin hydrochloride capsule USP for oral administration contains tamsulosin hydrochloride USP 0.4 mg, and the following inactive ingredients: microcrystalline cellulose, methacrylic acid copolymer dispersion, hypromellose acetate succinate, triethyl citrate, talc, and sodium lauryl sulfate.
The capsule shell contains gelatin, sodium lauryl sulfate, FD&C blue No. 2, ferric oxide red, ferric oxide yellow, and titanium dioxide.
Imprinting black ink contains shellac, dehydrated alcohol, butyl alcohol, propylene glycol, strong ammonia solution, black iron oxide, and potassium hydroxide.
It meets USP Dissolution Test 9.
Sources
Tamsulosin Hydrochloride Manufacturers
-
Proficient Rx Lp
![Tamsulosin Hydrochloride Capsule [Proficient Rx Lp]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Tamsulosin Hydrochloride | Proficient Rx Lp
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Northwind Pharmaceuticals, Llc
Tamsulosin Hydrochloride | Northwind Pharmaceuticals, Llc
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Blenheim Pharmacal, Inc.
Tamsulosin Hydrochloride | Blenheim Pharmacal, Inc.
Tamsulosin hydrochloride capsules USP, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules USP can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules USP, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Wockhardt Usa Llc
Tamsulosin Hydrochloride | Wockhardt Usa Llc
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [ see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Synthon Pharmaceuticals, Inc.
Tamsulosin Hydrochloride | Synthon Pharmaceuticals, Inc.
Tamsulosin hydrochloride capsules, USP 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules, USP can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules, USP 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules, USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Wockhardt Limited
Tamsulosin Hydrochloride | Wockhardt Limited
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [ see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Contract Pharmacy Services-pa
Tamsulosin Hydrochloride | Contract Pharmacy Services-pa
Tamsulosin hydrochloride capsules, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see WARNINGS AND PRECAUTIONS (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Ncs Healthcare Of Ky, Inc Dba Vangard Labs
Tamsulosin Hydrochloride | Cardinal Health
2.1 AdultsThe usual initial antihypertensive oral dose of amlodipine besylate tablets is 5 mg once daily with a maximum dose of 10 mg once daily.
Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily and this dose may be used when adding amlodipine besylate tablets to other antihypertensive therapy.
Adjust dosage according to each patient’s need. In general, titration should proceed over 7 to 14 days so that the physician can fully assess the patient’s response to each dose level. Titration may proceed more rapidly, however, if clinically warranted, provided the patient is assessed frequently.
The recommended dose for chronic stable or vasospastic angina is 5 to 10 mg, with the lower dose suggested in the elderly and in patients with hepatic insufficiency. Most patients will require 10 mg for adequate effect [see ADVERSE REACTIONS (6)].
The recommended dose range for patients with coronary artery disease is 5 to 10 mg once daily. In clinical studies, the majority of patients required 10 mg [see CLINICAL STUDIES (14.4)].
2.2 ChildrenThe effective antihypertensive oral dose in pediatric patients ages 6 to 17 years is 2.5 mg to 5 mg once daily. Doses in excess of 5 mg daily have not been studied in pediatric patients [see CLINICAL PHARMACOLOGY (12.4), CLINICAL STUDIES (14.1)].
-
Remedyrepack Inc.
Tamsulosin Hydrochloride | Remedyrepack Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Stat Rx Usa Llc
Tamsulosin Hydrochloride | Stat Rx Usa Llc
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [ see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Remedyrepack Inc.
Tamsulosin Hydrochloride | Remedyrepack Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole)
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Cadila Healthcare Limited
Tamsulosin Hydrochloride | Cadila Healthcare Limited
Tamsulosin hydrochloride capsules, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see WARNINGS AND PRECAUTIONS (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Global Pharmaceuticals, Division Of Impax Laboratories Inc.
Tamsulosin Hydrochloride | Global Pharmaceuticals, Division Of Impax Laboratories Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Physicians Total Care, Inc.
Tamsulosin Hydrochloride | Physicians Total Care, Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Rebel Distributors Corp
Tamsulosin Hydrochloride | Rebel Distributors Corp
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
H.j. Harkins Company, Inc.
Tamsulosin Hydrochloride | H.j. Harkins Company, Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [ see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Sun Pharmaceutical Industries Limited
Tamsulosin Hydrochloride | Pfizer Laboratories Div Pfizer Inc
Streptococcal (Group A) Upper Respiratory Infections (for example, pharyngitis)
Adults—a single injection of 1,200,000 units; older pediatric patients—a single injection of 900,000 units; infants and pediatric patients under 60 lbs.—300,000 to 600,000 units.
Syphilis
Primary, secondary, and latent—2,400,000 units (1 dose). Late (tertiary and neurosyphilis)—2,400,000 units at 7-day intervals for three doses.
Congenital—under 2 years of age: 50,000 units/kg/body weight; ages 2 to 12 years: adjust dosage based on adult dosage schedule.
Yaws, Bejel, and Pinta—1,200,000 units (1 injection).
Prophylaxis—for rheumatic fever and glomerulonephritis.
Following an acute attack, penicillin G benzathine (parenteral) may be given in doses of 1,200,000 units once a month or 600,000 units every 2 weeks.
-
Mylan Institutional Inc.
Tamsulosin Hydrochloride | Mylan Institutional Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. Tamsulosin hydrochloride capsules should not be crushed, chewed or opened.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Mckesson Packaging Services A Business Unit Of Mckesson Corporation
Tamsulosin Hydrochloride | Mckesson Packaging Services A Business Unit Of Mckesson Corporation
Tamsulosin hydrochloride capsules USP, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules USP can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules USP, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Remedyrepack Inc.
Tamsulosin Hydrochloride | Remedyrepack Inc.
Tamsulosin hydrochloride capsules USP, 0.4 mg once-daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules USP can be increased to 0.8 mg once-daily. Tamsulosin hydrochloride capsules USP, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Remedyrepack Inc.
Tamsulosin Hydrochloride | Remedyrepack Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [
see Warnings and Precautions (5.2)
].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Actavis Elizabeth Llc
Tamsulosin Hydrochloride | Actavis Elizabeth Llc
Tamsulosin hydrochloride capsules USP, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules USP can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules USP, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Mckesson Contract Packaging
Tamsulosin Hydrochloride | Mckesson Contract Packaging
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
St Marys Medical Park Pharmacy
Tamsulosin Hydrochloride | Western Family Foods Inc
• take only one dose per day (24 hours) – see Overdose warning • use dose cup adults & children 12 yrs & over 30 mL at bed time if needed or as directed by a doctor children under 12 yrs do not use Other information • each 30 mL dose cup contains: sodium 20 mg • store at 20-25˚C (68-77˚F) • protect from light. Does not meet USP <671>. -
Dispensing Solutions, Inc.
Tamsulosin Hydrochloride | Dispensing Solutions, Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Par Pharmaceutical
Tamsulosin Hydrochloride | Par Pharmaceutical
Tamsulosin Hydrochloride Capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. Tamsulosin hydrochloride capsules should not be crushed, chewed or opened.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Remedyrepack Inc.
Tamsulosin Hydrochloride | Remedyrepack Inc.
0.4 mg once daily taken approximately one-half hour following the same meal each day (2) Can be increased to 0.8 mg once daily for patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing (2) If discontinued or interrupted for several days, therapy should start again with the 0.4 mg once-daily dose (2)Tamsulosin hydrochloride capsules, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see WARNINGS AND PRECAUTIONS (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Pd-rx Pharmaceuticals, Inc.
Tamsulosin Hydrochloride | Cvs Pharmacy
• do not take more than 6 doses in any 24-hour period • measure only with dosing cup provided • do not use dosing cup with other products • mL = milliliterAge
Dose
children 6 years to under 12 years
5 mL – 10 mL every 4 hours
children 4 years to under 6 years
2.5 mL – 5 mL every 4 hours
children under 4 years
do not use
-
Sandoz Inc
Tamsulosin Hydrochloride | Temple Industrial Welding Supply Co
There is currently no dosage information available for this product. We apologize for any inconvenience.
-
Clinical Solutions Wholesale
Tamsulosin Hydrochloride | Clinical Solutions Wholesale
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Medvantx, Inc.
Tamsulosin Hydrochloride | Medvantx, Inc.
Tamsulosin hydrochloride capsules USP, 0.4 mg once-daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules USP can be increased to 0.8 mg once-daily. Tamsulosin hydrochloride capsules USP, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Lake Erie Medical Dba Quality Care Products Llc
Tamsulosin Hydrochloride | Lake Erie Medical Dba Quality Care Products Llc
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose -
Remedyrepack Inc.
Tamsulosin Hydrochloride | Remedyrepack Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [
see Warnings and Precautions (5.2)
].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Remedyrepack Inc.
Tamsulosin Hydrochloride | Remedyrepack Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [
see Warnings and Precautions (5.2)
].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Unit Dose Services
Tamsulosin Hydrochloride | Unit Dose Services
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [ ]. If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
see Warnings and Precautions ( ) 5.2
-
Golden State Medical Supply, Inc.
Tamsulosin Hydrochloride | Golden State Medical Supply, Inc.
Tamsulosin hydrochloride capsules USP, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules USP can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules USP, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Cardinal Health
Tamsulosin Hydrochloride | Cardinal Health
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Major Pharmaceuticals
Tamsulosin Hydrochloride | Major Pharmaceuticals
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Citron Pharma Llc
Tamsulosin Hydrochloride | Citron Pharma Llc
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. Tamsulosin hydrochloride capsules should not be crushed, chewed or opened.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Remedyrepack Inc.
Tamsulosin Hydrochloride | Remedyrepack Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [
see Warnings and Precautions (5.2)
].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
American Health Packaging
Tamsulosin Hydrochloride | Swabplus Inc.
For adults and children 2 and older: for minor wounds, burns and infections, apply directly to affected area. May be covered with a bandage.
Children under 2 years of age: Do not use, consult a doctor.
Other information: Store art room temperature, Avoid direct sunlight, excessive heat and moisture. -
Mckesson Packaging Services A Business Unit Of Mckesson Corporation
Tamsulosin Hydrochloride | Mckesson Packaging Services A Business Unit Of Mckesson Corporation
Tamsulosin hydrochloride capsules, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see WARNINGS AND PRECAUTIONS (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Aidarex Pharmaceuticals Llc
Tamsulosin Hydrochloride | Aidarex Pharmaceuticals Llc
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Remedyrepack Inc.
Tamsulosin Hydrochloride | Remedyrepack Inc.
Tamsulosin hydrochloride capsules USP, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules USP can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules USP, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Cardinal Health
Tamsulosin Hydrochloride | Cardinal Health
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Remedyrepack Inc.
Tamsulosin Hydrochloride | Remedyrepack Inc.
Tamsulosin hydrochloride capsules USP, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules USP can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules USP, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
State Of Florida Doh Central Pharmacy
Tamsulosin Hydrochloride | State Of Florida Doh Central Pharmacy
Tamsulosin hydrochloride capsules, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see WARNINGS AND PRECAUTIONS (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Aphena Pharma Solutions – Tennessee, Llc
Tamsulosin Hydrochloride | Aphena Pharma Solutions - Tennessee, Llc
Tamsulosin hydrochloride capsules USP, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules USP can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules USP, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Preferred Pharmaceuticals, Inc
Tamsulosin Hydrochloride | Preferred Pharmaceuticals, Inc
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Preferred Pharmaceuticals, Inc.
Tamsulosin Hydrochloride | Preferred Pharmaceuticals, Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. -
Bryant Ranch Prepack
Tamsulosin Hydrochloride | Bryant Ranch Prepack
Tamsulosin hydrochloride capsules, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see WARNINGS AND PRECAUTIONS (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Carilion Materials Management
Tamsulosin Hydrochloride | Carilion Materials Management
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [ ]. If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
see Warnings and Precautions ( ) 5.2
-
Teva Pharmaceuticals Usa Inc
Tamsulosin Hydrochloride | La Prairie, Inc.
• apply daily after cleansing and toning • smooth over face and throat • apply liberally 15 minutes before sun exposure • children under 6 months of age: Ask a doctor • reapply at least every 2 hours • use a water resistant sunscreen if swimming or sweating • Sun Protection Measures. Spending time in the sun increase your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: • Limit time in the sun, especially from 10 a.m. - 2 p.m. • Wear long-sleeve shirts, pants, hats and sunglasses
-
Zydus Pharmaceuticals (Usa) Inc.
Tamsulosin Hydrochloride | Zydus Pharmaceuticals (usa) Inc.
Tamsulosin hydrochloride capsules, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. Tamsulosin hydrochloride capsules should not be crushed, chewed or opened.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see WARNINGS AND PRECAUTIONS (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Remedyrepack Inc.
Tamsulosin Hydrochloride | Remedyrepack Inc.
0.4 mg once daily taken approximately one-half hour following the same meal each day (2) Can be increased to 0.8 mg once daily for patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing (2) If discontinued or interrupted for several days, therapy should start again with the 0.4 mg once-daily dose (2)Tamsulosin hydrochloride capsules, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see WARNINGS AND PRECAUTIONS (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Aurobindo Pharma Limited
Tamsulosin Hydrochloride | Aurobindo Pharma Limited
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. Tamsulosin hydrochloride capsules should not be crushed, chewed or opened.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules
administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
-
Mylan Pharmaceuticals Inc.
Tamsulosin Hydrochloride | Actavis Pharma, Inc.
2.1 Initial DosingMorphine sulfate extended-release should be prescribed only by healthcare professionals who are knowledgeable in the use of potent opioids for the management of chronic pain.
Initiate the dosing regimen for each patient individually, taking into account the patient's prior analgesic treatment experience and risk factors for addiction, abuse, and misuse [see Warnings and Precautions (5.1)]. Monitor patients closely for respiratory depression, especially within the first 24 to 72 hours of initiating therapy with morphine sulfate extended-release [see Warnings and Precautions (5.2)].
Morphine sulfate extended-release tablets must be taken whole. Crushing, chewing, or dissolving morphine sulfate extended-release tablets will result in uncontrolled delivery of morphine and can lead to overdose or death [see Warnings and Precautions (5.1)].
Use of Morphine Sulfate Extended-Release as the First Opioid Analgesic
Initiate treatment with morphine sulfate extended-release with 15 mg tablets orally every 8 or 12 hours.
Use of Morphine Sulfate Extended-Release in Patients who are not Opioid Tolerant
The starting dose for patients who are not opioid tolerant is morphine sulfate extended-release 15 mg orally every 12 hours. Patients who are opioid tolerant are those receiving, for one week or longer, at least 60 mg oral morphine per day, 25 mg mcg transdermal fentanyl per hour, 30 mg oral oxycodone per day, 8 mg oral hydromorphone per day, 25 mg oral oxymorphone per day, or an equianalgesic dose of another opioid.
Use of higher starting doses in patients who are not opioid tolerant may cause fatal respiratory depression.
Conversion from Other Oral Morphine to Morphine Sulfate Extended-Release
Patients receiving other oral morphine formulations may be converted to morphine sulfate extended-release by administering one-half of the patient's 24-hour requirement as morphine sulfate extended-release on an every-12-hour schedule or by administering one-third of the patient's daily requirement as morphine sulfate extended-release on an every-8-hour schedule.
Conversion from Other Opioids to Morphine Sulfate Extended-Release
There are no established conversion ratios for conversion from other opioids to morphine sulfate extended-release defined by clinical trials. Discontinue all other around-the-clock opioid drugs when morphine sulfate extended-release therapy is initiated and initiate dosing using morphine sulfate extended-release 15 mg orally every 8 to 12 hours.
It is safer to underestimate a patient’s 24-hour oral morphine requirements and provide rescue medication (e.g., immediate-release morphine) than to overestimate the 24-hour oral morphine requirements and manage an adverse reaction. While useful tables of opioid equivalents are readily available, there is substantial inter-patient variability in the relative potency of different opioid drugs and products.
Conversion from Parenteral Morphine or Other Opioids (Parenteral or Oral) to Morphine Sulfate Extended-Release
When converting from parenteral morphine or other non-morphine opioids (parenteral or oral) to morphine sulfate extended-release, consider the following general points:
Parenteral to oral morphine ratio: Between 2 to 6 mg of oral morphine may be required to provide analgesia equivalent to 1 mg of parenteral morphine. Typically, a dose of morphine that is approximately three times the previous daily parenteral morphine requirement is sufficient.
Other parenteral or oral non-morphine opioids to oral morphine sulfate: Specific recommendations are not available because of a lack of systematic evidence for these types of analgesic substitutions. Published relative potency data are available, but such ratios are approximations. In general, begin with half of the estimated daily morphine requirement as the initial dose, managing inadequate analgesia by supplementation with immediate-release morphine.
Conversion from Methadone to Morphine Sulfate Extended-Release
Close monitoring is of particular importance when converting methadone to other opioid agonists. The ratio between methadone and other opioid agonists may vary widely as a function of previous dose exposure. Methadone has a long half-life and can accumulate in the plasma.
2.2 Titration and Maintenance of TherapyIndividually titrate morphine sulfate extended-release to a dose that provides adequate analgesia and minimizes adverse reactions. Continually reevaluate patients receiving morphine sulfate extended-release to assess the maintenance of pain control and the relative incidence of adverse reactions, as well as monitoring for the development of addiction, abuse, or misuse. Frequent communication is important among the prescriber, other members of the healthcare team, the patient, and the caregiver/family during periods of changing analgesic requirements, including initial titration. During chronic therapy periodically reassess the continued need for the use of opioid analgesics.
Patients who experience breakthrough pain may require a dose increase of morphine sulfate extended-release, or may need rescue medication with an appropriate dose of an immediate-release analgesic. If the level of pain increases after dose stabilization, attempt to identify the source of increased pain before increasing the morphine sulfate extended-release dose. Because steady-state plasma concentrations are approximated in 1 day, morphine sulfate extended-release dosage adjustments may be done every 1 to 2 days.
If unacceptable opioid-related adverse reactions are observed, the subsequent doses may be reduced. Adjust the dose to obtain an appropriate balance between management of pain and opioid-related adverse reactions.
2.3 Discontinuation of Morphine Sulfate Extended-ReleaseWhen the patient no longer requires therapy with morphine sulfate extended-release, use a gradual downward titration of the dose to prevent signs and symptoms of withdrawal in the physically-dependent patient. Do not abruptly discontinue morphine sulfate extended-release.
2.4 Administration of Morphine Sulfate Extended-Release TabletsMorphine sulfate extended-release tablets must be taken whole. Crushing, chewing, or dissolving morphine sulfate extended-release tablets will result in uncontrolled delivery of morphine and can lead to overdose or death [see Warnings and Precautions (5.1)].
-
Cardinal Health
Tamsulosin Hydrochloride | Cardinal Health
Patients Not Taking a Phosphate Binder. The recommended starting dose of Renagel is 800 to 1600 mg, which can be administered as one or two 800 mg Renagel® Tablets or two to four 400 mg Renagel® Tablets, with meals based on serum phosphorus level. Table 1 provides recommended starting doses of Renagel for patients not taking a phosphate binder.
Table 1. Starting Dose for Dialysis Patients Not Taking a Phosphate Binder Serum Phosphorus Renagel® 800 mg Renagel® 400 mg> 5.5 and < 7.5 mg/dL
1 tablet three times daily with meals
2 tablets three times daily with meals
≥ 7.5 and < 9.0 mg/dL
2 tablets three times daily with meals
3 tablets three times daily with meals
≥ 9.0 mg/dL
2 tablets three times daily with meals
4 tablets three times daily with meals
Patients Switching From Calcium Acetate. In a study in 84 CKD patients on hemodialysis, a similar reduction in serum phosphorus was seen with equivalent doses (approximately mg for mg) of Renagel and calcium acetate. Table 2 gives recommended starting doses of Renagel based on a patient's current calcium acetate dose.
Table 2. Starting Dose for Dialysis Patients Switching From Calcium Acetate to Renagel Calcium Acetate 667 mg
(Tablets per meal) Renagel® 800 mg
(Tablets per meal) Renagel® 400 mg
(Tablets per meal)1 tablet
1 tablet
2 tablets
2 tablets
2 tablets
3 tablets
3 tablets
3 tablets
5 tablets
Dose Titration for All Patients Taking Renagel. Dosage should be adjusted based on the serum phosphorus concentration with a goal of lowering serum phosphorus to 5.5 mg/dL or less. The dose may be increased or decreased by one tablet per meal at two week intervals as necessary. Table 3 gives a dose titration guideline. The average dose in a Phase 3 trial designed to lower serum phosphorus to 5.0 mg/dL or less was approximately three Renagel 800 mg tablets per meal. The maximum average daily Renagel dose studied was 13 grams.
Table 3. Dose Titration Guideline Serum Phosphorus
Renagel® Dose
>5.5 mg/dL
Increase 1 tablet per meal at 2 week intervals
3.5 - 5.5 mg/dL
Maintain current dose
<3.5 mg/dL
Decrease 1 tablet per meal
-
Clinical Solutions Wholesale, Llc
Tamsulosin Hydrochloride | Clinical Solutions Wholesale, Llc
Tamsulosin hydrochloride capsules USP, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules USP can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules USP, 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.
![Tamsulosin Hydrochloride Capsule [Northwind Pharmaceuticals, Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=815595c6-740b-4262-934e-8aa4df073d91&name=51655-677-26.jpg)
![Tamsulosin Hydrochloride Capsule [Blenheim Pharmacal, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0f553cbe-ba5e-283e-e054-00144ff88e88&name=LABEL_TAMSULOSINHCICAPS0-4MG_BPI(10544-280-30)_ACTIVAS(0228-2996-11)_REV1-Copy.jpg)
![Tamsulosin Hydrochloride Capsule [Wockhardt Usa Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=bcd86877-5868-49dd-840b-7860b405fac7&name=TamsulosinHClCapsules_ContainerLabel100Tablets.jpg)
![Tamsulosin Hydrochloride Capsule [Synthon Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=13a5032d-0be1-4001-916e-459f0b1a051d&name=tamsulosin-07.jpg)
![Tamsulosin Hydrochloride Capsule [Wockhardt Limited]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aecd6c1b-d3e3-4568-b8cb-89954f0aee5d&name=TamsulosinHClCapsules_ContainerLabel100Tablets.jpg)
![Tamsulosin Hydrochloride Capsule [Contract Pharmacy Services-pa]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7350ad6e-7745-4743-9aa4-2a14ff01fef4&name=7350ad6e-7745-4743-9aa4-2a14ff01fef4-07.jpg)
![Tamsulosin Hydrochloride Capsule [Ncs Healthcare Of Ky, Inc Dba Vangard Labs]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a74239bf-4684-424c-ba4e-6087e363265b&name=image-01.jpg)
![Tamsulosin Hydrochloride (Tamsulosin Hydrochloride) Capsule [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c32e14cb-8c76-450d-9b86-993fa7a826b2&name=MM7.jpg)
![Tamsulosin Hydrochloride Capsule [Stat Rx Usa Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f2bb56f9-0e60-4462-b17b-46b49638a841&name=TAMSULOSINHCLLABEL298.jpg)
![Tamsulosin Hydrochloride Capsule [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=ea4bf1f5-acb3-4da7-9b54-d4c97f31a964&name=MM7.jpg)
![Tamsulosin Hydrochloride Capsule [Cadila Healthcare Limited]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=276c7e26-f86a-46b9-b626-ceef76b729a4&name=tamsulosin(manu)-figure-07.jpg)
![Tamsulosin Hydrochloride Capsule [Global Pharmaceuticals, Division Of Impax Laboratories Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c3ae55dd-6a0e-4f3a-82b6-2448e0545550&name=tamsulosin-07.jpg)
![Tamsulosin Hydrochloride Capsule [Physicians Total Care, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=dda1de08-d3c3-49c7-bd3c-5842f65d5662&name=packagelabel.jpg)
![Tamsulosin Hydrochloride Capsule [Rebel Distributors Corp]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1ceb560b-1a62-408d-8e30-23113e8c9dd3&name=1ceb560b-1a62-408d-8e30-23113e8c9dd3-07.jpg)
![Tamsulosin Hydrochloride Capsule [H.j. Harkins Company, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=af558603-15f3-43e4-9ee5-9d38d59ef1c1&name=TamsulosinHClCapsules_ContainerLabel100Tablets.jpg)
![Tamsulosin Hydrochloride Capsule [Sun Pharmaceutical Industries Limited ]](https://www.recallguide.org/wp-content/themes/bootstrap/assets/img/drug-image-placeholder.jpg)
![Tamsulosin Hydrochloride Capsule [Mylan Institutional Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=50cc1acc-1544-4f71-8beb-19b0e57b4b6b&name=image-01.jpg)
![Tamsulosin Hydrochloride Capsule [Mckesson Packaging Services A Business Unit Of Mckesson Corporation]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=acbaeb6c-1198-4d11-8016-e8b6dcbbc5d9&name=acbaeb6c-1198-4d11-8016-e8b6dcbbc5d9-07.jpg)
![Tamsulosin Hydrochloride Capsule [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d302b0fb-4f03-4106-b484-1e811f62c356&name=MM7.jpg)
![Tamsulosin Hydrochloride Capsule [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=301a49d7-717d-4a24-8d67-97a3e852472b&name=MM7.jpg)
![Tamsulosin Hydrochloride Capsule [Actavis Elizabeth Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=339c3b57-a339-4578-bfd7-46b25d911ff6&name=ab8b786d-figure-01.jpg)
![Tamsulosin Hydrochloride Capsule [Mckesson Contract Packaging]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=148826a2-5a25-4e70-a086-a2f04eff9849&name=148826a2-5a25-4e70-a086-a2f04eff9849-07.jpg)
![Tamsulosin Hydrochloride Capsule [St Marys Medical Park Pharmacy]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=adc09089-4e20-490e-a0c5-5f4db400ae83&name=bb207d91-a5e2-4fe8-a979-fb6a0e0377e0-01.jpg)
![Tamsulosin Hydrochloride Capsule [Dispensing Solutions, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1d845218-1562-42a2-98fe-3b13cd5d0542&name=NDC66336-0902-XX------CARACO.jpg)
![Tamsulosin Hydrochloride Capsule [Par Pharmaceutical]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=423f410e-10e8-4fda-8249-d0f6cdefc5d7&name=cb024895-6fbb-4375-a3a9-8654ad5b6d0d-07.jpg)
![Tamsulosin Hydrochloride Capsule [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=56158554-4f15-4588-8d2b-263607e684a3&name=MM7.jpg)
![Tamsulosin Hydrochloride Capsule [Pd-rx Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8013d237-603a-4b37-9d48-6b36a3b173de&name=871ecf4c-4c67-4b5f-b630-46bb2e3fd5bd-01.jpg)
![Tamsulosin Hydrochloride Capsule [Sandoz Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=24168cb8-6b32-437d-bbe2-e0f28c90c171&name=liquidoxygen.jpg)
![Tamsulosin Hydrochloride Capsule [Clinical Solutions Wholesale]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=20a8e32e-f0a8-4edc-9dad-e6a7f7b9a509&name=Tam.4Lab0.jpg)
![Tamsulosin Hydrochloride Capsule [Medvantx, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=cf8f5d60-a2f8-4fa4-ba39-6d175cf3abce&name=cf8f5d60-a2f8-4fa4-ba39-6d175cf3abce-07.jpg)
![Tamsulosin Hydrochloride Capsule [Lake Erie Medical Dba Quality Care Products Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7cf4ab7d-2626-4c42-bd53-8e7c2e6e886c&name=TamsulosinHCl04mgWockhardt.jpg)
![Tamsulosin Hydrochloride Capsule [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1538f06a-8c1d-4105-9c20-d14bdefe8ef9&name=MM7.jpg)
![Tamsulosin Hydrochloride Capsule [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=569e92f1-418d-4e44-9f53-5d9e73359416&name=MM7.jpg)
![Tamsulosin Hydrochloride Capsule [Unit Dose Services]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=ca0c8c0f-9d72-4de0-8931-e233a9d7b429&name=50436-0119.jpg)
![Tamsulosin Hydrochloride Capsule [Golden State Medical Supply, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1a8003d3-b990-4462-a787-ab93ca72f7b7&name=1a8003d3-b990-4462-a787-ab93ca72f7b7-07.jpg)
![Tamsulosin Hydrochloride Capsule [Cardinal Health]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=818d8158-f365-4047-9305-f822691e31ae&name=818d8158-f365-4047-9305-f822691e31ae-07.jpg)
![Tamsulosin Hydrochloride Capsule [Major Pharmaceuticals]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=ba30cac2-62d9-4964-97ea-10ad751985e4&name=tamsulosin-hcl-capsules-7.jpg)
![Tamsulosin Hydrochloride Capsule [Citron Pharma Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a242c8dc-576e-4a1f-a9e7-a05d7ebc0e0a&name=tamsulosin-fig6.jpg)
![Tamsulosin Hydrochloride Capsule [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b31a5285-27e9-45a0-8e11-fb987db46d85&name=MM7.jpg)
![Tamsulosin Hydrochloride Capsule [American Health Packaging]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8629d5dd-2a59-4184-89e5-d63b77e66226&name=Isodine02511.jpg)
![Tamsulosin Hydrochloride Capsule [Mckesson Packaging Services A Business Unit Of Mckesson Corporation]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c9084267-e096-4dfb-b364-1a218c9d6985&name=45e97516-5a96-470d-92e2-dd9d85bb170c-07.jpg)
![Tamsulosin Hydrochloride Capsule [Aidarex Pharmaceuticals Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a82c4269-b53d-4e7f-877a-88f005826678&name=tamsulosin-hcl-0-4mg-cap-for-wockhardt-7.jpg)
![Tamsulosin Hydrochloride Capsule [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=836447d8-fdea-4fa7-bb2f-e269fcb251f9&name=MM7.jpg)
![Tamsulosin Hydrochloride Capsule, Gelatin Coated [Cardinal Health]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=dddbccd5-306b-47cd-a14e-3ba3ca013988&name=4c3bd5be-5d46-42f2-8765-a397cbde2f88-07.jpg)
![Tamsulosin Hydrochloride Capsule [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2a2a3134-f110-4668-ae25-391afab77f99&name=MM7.jpg)
![Tamsulosin Hydrochloride Capsule [State Of Florida Doh Central Pharmacy]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4ef1a932-b5b2-4ea7-a625-388dd78f9058&name=TamsulosinHCL0.4MG.jpg)
![Tamsulosin Hydrochloride Capsule [Aphena Pharma Solutions – Tennessee, Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d48bffcf-1070-46b0-a5f8-8ea1aa53ba27&name=43353-663.jpg)
![Tamsulosin Hydrochloride Capsule [Preferred Pharmaceuticals, Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=6fb8a408-8e63-41f0-adc3-ddac62b64503&name=6fb8a408-8e63-41f0-adc3-ddac62b64503-07.jpg)
![Tamsulosin Hydrochloride Capsule [Preferred Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=feebbae8-f226-45b2-b284-edf43b178fbb&name=label-30crc.jpg)
![Tamsulosin Hydrochloride Capsule [Bryant Ranch Prepack]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e9372720-bd02-e4a6-0afd-42fe0c661c00&name=label1datamaxfda321.jpg)
![Tamsulosin Hydrochloride Capsule [Carilion Materials Management]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=94dc4410-ef44-4e4c-ace3-859539721540&name=68151-2346.jpg)
![Tamsulosin Hydrochloride Capsule [Zydus Pharmaceuticals (Usa) Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=300be29a-c56d-4daa-ba89-f207c281ea20&name=tamsulosinhydrochloride1-figure-07.jpg)
![Tamsulosin Hydrochloride Capsule [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c46fa467-e70f-44f3-857d-8eaf0a253640&name=MM7.jpg)
![Tamsulosin Hydrochloride Capsule [Aurobindo Pharma Limited]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8cb27f78-2d5d-4640-b7b5-ed06973c8133&name=tamsulosin-fig6.jpg)
![Tamsulosin Hydrochloride Capsule [Clinical Solutions Wholesale, Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=bc5b255a-052a-4d3f-baa3-10b20dbfb99d&name=ab8b786d-figure-07.jpg)
Login To Your Free Account